Allozymes utilizes proprietary microfluidics technology to rapidly engineer and optimize custom enzymes, significantly increasing the speed of development and success rates in enzyme production. This approach addresses the environmental impact of traditional manufacturing methods by providing cleaner, more efficient biocatalytic processes for producing natural ingredients.

Arkeon Bio utilizes ancient archaea to convert industrial CO2 and inorganic gases into climate-positive protein ingredients for food. This process addresses the dual challenges of carbon emissions and food sustainability by providing ethical, cruelty-free, and adaptable nutritional solutions.

Avant Meats utilizes patent-pending cell cultivation technology to produce fish products without the need for traditional fishing methods, ensuring they are free from heavy metals and microplastics. This approach addresses the depletion of ocean fish stocks by providing a sustainable and scalable alternative for nutritious seafood.

Bond Pet Foods utilizes biotechnology to produce nature-identical animal proteins through fermentation processes, eliminating the need for traditional livestock farming. This approach addresses the environmental impact of pet food production by providing sustainable, scalable protein sources that meet the nutritional needs of dogs and cats.

Chromologics utilizes a fungal fermentation platform to produce natural food colorants, specifically Natu.Red® for food and beverage applications and Sustainly.Red® for non-food industries like textiles and cosmetics. Their colorants offer superior stability and reliable sourcing, providing a sustainable alternative to artificial dyes while meeting the performance needs of various applications.

Clever Carnivore utilizes cellular agriculture to produce cultivated pork products, eliminating the need for animal slaughter and significantly reducing land and water use by over 95%. This approach addresses food insecurity and environmental degradation by providing a sustainable, cruelty-free source of meat that minimizes greenhouse gas emissions and contamination risks.

Core Biogenesis utilizes proprietary plant-based bioproduction technologies to manufacture animal-free, endotoxin-free recombinant growth factors and cytokines for cell culture applications. This approach enhances the consistency and reproducibility of cell cultures, addressing the critical issue of endotoxin contamination in biomanufacturing processes.

EvodiaBio utilizes biotechnological processes to create natural scent compounds for the food and beverage industries, replacing synthetic fragrances with sustainable alternatives. This approach meets the growing consumer demand for cleaner ingredients while enhancing the sensory appeal of products.

This startup produces cultivated meat products through cell cultivation techniques, significantly reducing land and resource use while maintaining the taste and texture of traditional meat. Their flagship offering, cultivated foie gras, honors culinary heritage while providing a sustainable alternative to conventional meat production.

Liberation Labs utilizes precision fermentation technology to produce alternative proteins and bioproducts at commercial scale, addressing the capacity bottlenecks in biomanufacturing. Their facility in Indiana aims to meet the growing demand for sustainable and environmentally friendly food and materials, enabling manufacturers to efficiently scale their production.

The startup develops a fasting mimetic that utilizes a specific combination of bioactive human metabolites to replicate the cellular health benefits of fasting. This approach provides anti-inflammatory and antioxidant effects, addressing age-associated chronic inflammation and cellular damage without the need for actual fasting.

The startup develops all-natural preservatives by extracting proteins from natural silk using a simple salt and water process, creating a protective layer that extends the shelf life of food products. This technology reduces food waste and enhances the sustainability of the food supply chain by providing an economical solution for the food, agriculture, and packaging industries.

New Age Meats is a biotechnology company that cultivates meat from animal cells, eliminating the need for animal slaughter. This method addresses ethical concerns and aims to provide a healthier, sustainable alternative to traditional meat production.

People Science is a technology-enabled clinical research platform that utilizes data collection tools to conduct rigorous studies on alternative medicines and wellness interventions. The platform empowers consumers to explore personalized health solutions while providing companies with reliable scientific evidence to enhance their product development.

Pivot Bio is an agricultural technology company that utilizes microbial solutions to convert atmospheric nitrogen into a form that is readily accessible to plants. This process enhances soil fertility and reduces the reliance on synthetic fertilizers, addressing nutrient deficiencies in crops.

Pow.bio has developed a high-efficiency fermentation platform that decouples biomass growth from product production, addressing issues of contamination and genetic drift in biomanufacturing. This technology enables manufacturers to achieve 2-5 times more product output while reducing production costs by 40-70%.

Protealis develops and supplies high-performance soybean varieties optimized for European cultivation and protein production. The company focuses on data-backed breeding technology to deliver superior yield and protein content for the feed and food supply chain. They aim to strengthen regional legume production through advanced agricultural science and farmer collaboration.

Switch Bioworks engineers naturally occurring microbes formulated into a powder that farmers apply at sowing. These microbes colonize plant roots and produce nitrogen fertilizer directly where it is needed. This process reduces input costs, minimizes agricultural runoff, and mitigates supply chain risks associated with traditional fertilizer.

Synonym develops biomanufacturing infrastructure and a dynamic database of contract manufacturers to facilitate the commercialization of next-generation bioproducts. By providing techno-economic analysis and lifecycle assessments, the company helps businesses scale production efficiently while addressing the challenges of supply chain sustainability and decarbonization.

The startup has developed a scalable cell separation technology utilizing multiplexed microfluidic devices for industrial-scale liquid particle processing, including cell separation and pathogen concentration. This technology offers a cost-effective alternative to traditional methods such as filtration, flow centrifugation, and flocculation, significantly enhancing throughput and efficiency in various industries.

The startup operates a medical monitoring platform that utilizes enzymatic assays to quantify and analyze enzyme activity in complex research settings. This technology enables healthcare professionals to tailor diagnostic approaches based on precise enzymatic measurements, enhancing the accuracy of patient assessments.